mRNA |
tretinoin:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.015 |
0.7 |
mRNA |
tretinoin:carboplatin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.004 |
0.9 |
mRNA |
tosedostat |
CTRPv2 |
pan-cancer |
AAC |
0.058 |
0.1 |
mRNA |
tivozanib |
CTRPv2 |
pan-cancer |
AAC |
-0.0069 |
0.9 |
mRNA |
tivozanib |
GDSC1000 |
pan-cancer |
AAC |
0.04 |
0.2 |
mRNA |
tivantinib |
CTRPv2 |
pan-cancer |
AAC |
-0.05 |
0.3 |
mRNA |
tipifarnib |
CTRPv2 |
pan-cancer |
AAC |
-0.056 |
0.07 |
mRNA |
tigecycline |
CTRPv2 |
pan-cancer |
AAC |
-0.034 |
0.5 |
mRNA |
thapsigargin |
gCSI |
pan-cancer |
AAC |
-0.089 |
0.1 |
mRNA |
thapsigargin |
GDSC1000 |
pan-cancer |
AAC |
-0.065 |
0.07 |